Business Context and Reporting Period
Quince Therapeutics, Inc. (QNCX) filed a Current Report on Form 8-K on June 26, 2026. The filing details the implementation of a reverse stock split previously approved by stockholders at the 2025 Annual Meeting. The company is incorporated in Delaware and trades on the Nasdaq Global Select Market.
Key Financial Metrics
This filing is a corporate action report and does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The filing text does not provide a clear value for these items.
Material Changes
- Reverse Stock Split: The Board of Directors approved a 1-for-20 reverse stock split. The Certificate of Amendment was filed with the Delaware Secretary of State on June 26, 2026, and became effective at 11:59 pm Eastern Time on June 29, 2026.
- Share Count Reduction: Outstanding shares decreased from 19,559,257 immediately prior to the split to approximately 977,963 immediately after effectiveness.
- Trading Adjustments: Common stock began trading on a split-adjusted basis on June 30, 2026, under the symbol "QNCX" with a new CUSIP number (22053A305).
- Derivatives Adjustment: All outstanding stock options and warrants were proportionally adjusted.
- Fractional Shares: Stockholders entitled to fractional shares received cash in lieu thereof.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, management commentary on future outlook, or specific risk factors beyond the standard disclosure that the discussion is qualified by the full text of the Certificate of Amendment. The primary purpose of the filing is to notify the market of the completed corporate action.
Investor Verification Checklist
- Verify the new CUSIP number (22053A305) for trading purposes effective June 30, 2026.
- Confirm that brokerage accounts reflect the 1-for-20 adjustment and any cash payments for fractional shares.
- Review the adjusted terms of any outstanding stock options or warrants held.
- Check the post-split share count of approximately 977,963 shares.